Nanovibronix today announced successful results for its PainShield™ device in treating patients with Trigeminal Neuralgia. The double blinded, crossover trial was conducted across the US and included 59 patients with a diagnosis of unilateral trigeminal neuralgia. There was a significant difference in the outcomes of the two groups relative to pain, quality of life, and breakthrough medications taken, which was directly correlated to pain experienced during treatment.Read More
A sound solution for Trigeminal Neuralgia.
Haim- Moshe Adahan, Head of the Pain Rehabilitation Unit, Sheba Medical Center
Yaacov Ezra, Staff Neurology & Pain Divisions, Hadassah Hospital of Jerusalem
Itschak Siev-Ner, Head of the Orthopedic Rehabilitation Division, Sheba Medical Center